Adverum Biotechnologies, Inc. recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating changes in the ownership of company insiders or major shareholders. Form 4 is a document required to be filed with the SEC whenever there are changes in the holdings of company insiders, such as directors, officers, or beneficial owners. These changes could include purchases or sales of company stock, stock option exercises, or other securities transactions.
Adverum Biotechnologies, Inc. is a biotechnology company focused on developing gene therapies for the treatment of serious ocular and rare diseases. The company’s innovative platform aims to address unmet medical needs and improve the lives of patients. For more information about Adverum Biotechnologies, Inc., you can visit their website here.
Overall, the filing of Form 4 by Adverum Biotechnologies, Inc. provides valuable insights into the ownership structure of the company and any recent transactions by insiders. Investors and stakeholders may use this information to gauge the confidence of company insiders in its future prospects and make informed decisions regarding their investment in the company.
Read More:
Adverum Biotechnologies, Inc. Files SEC Form 4 – Learn More About the Issuer
Leave a Reply